Nakano D[Author] - Search Results

Year	Number of Results
1975	1
1976	1
1979	1
1981	1
1988	1
1999	1
2001	1
2002	1
2003	1
2005	2
2006	5
2007	4
2008	7
2009	14
2010	22
2011	24
2012	21
2013	18
2014	8
2015	8
2016	13
2017	16
2018	25
2019	21
2020	27
2021	34
2022	22

1

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD.

Yamamura S, Eslam M, Kawaguchi T, Tsutsumi T, Nakano D, Yoshinaga S, Takahashi H, Anzai K, George J, Torimura T. Yamamura S, et al. Among authors: nakano d. Liver Int. 2020 Dec;40(12):3018-3030. doi: 10.1111/liv.14675. Liver Int. 2020. PMID: 32997882

2

MAFLD: Renovation of clinical practice and disease awareness of fatty liver.

Kawaguchi T, Tsutsumi T, Nakano D, Torimura T. Kawaguchi T, et al. Among authors: nakano d. Hepatol Res. 2022 May;52(5):422-432. doi: 10.1111/hepr.13706. Epub 2021 Sep 17. Hepatol Res. 2022. PMID: 34472683 Review.

3

A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice.

Zhang Y, Nakano D, Guan Y, Hitomi H, Uemura A, Masaki T, Kobara H, Sugaya T, Nishiyama A. Zhang Y, et al. Among authors: nakano d. Kidney Int. 2018 Sep;94(3):524-535. doi: 10.1016/j.kint.2018.05.002. Epub 2018 Jul 23. Kidney Int. 2018. PMID: 30045814 Free article.

4

[Erythropoietin-producing cells].

Nakano D. Nakano D. Nihon Yakurigaku Zasshi. 2016;148(5):281. doi: 10.1254/fpj.148.281. Nihon Yakurigaku Zasshi. 2016. PMID: 27803443 Japanese. No abstract available.

5

[Colorectal cancer].

Takahashi K, Matsumoto H, Yamaguchi T, Nakano D, Miyatani T. Takahashi K, et al. Among authors: nakano d. Gan To Kagaku Ryoho. 2009 Sep;36(9):1408-13. Gan To Kagaku Ryoho. 2009. PMID: 19755808 Review. Japanese.

6

Antitumor Allium Sulfides.

Nohara T, Fujiwara Y, El-Aasr M, Ikeda T, Ono M, Nakano D, Kinjo J. Nohara T, et al. Among authors: nakano d. Chem Pharm Bull (Tokyo). 2017;65(3):209-217. doi: 10.1248/cpb.c16-00844. Chem Pharm Bull (Tokyo). 2017. PMID: 28250342 Free article. Review.

7

Sodium/glucose cotransporter 2 and renoprotection: From the perspective of energy regulation and water conservation.

Kitada K, Kidoguchi S, Nakano D, Nishiyama A. Kitada K, et al. Among authors: nakano d. J Pharmacol Sci. 2021 Nov;147(3):245-250. doi: 10.1016/j.jphs.2021.07.006. Epub 2021 Aug 5. J Pharmacol Sci. 2021. PMID: 34507633 Free article. Review.

8

Prorenin/renin and insulin resistance.

Rafiq K, Nagai Y, Nakano D. Rafiq K, et al. Among authors: nakano d. Front Biosci (Elite Ed). 2010 Jun 1;2(3):1143-6. doi: 10.2741/e173. Front Biosci (Elite Ed). 2010. PMID: 20515785 Free article. Review.

9

Multiphoton imaging of kidney pathophysiology.

Nakano D, Nishiyama A. Nakano D, et al. J Pharmacol Sci. 2016 Sep;132(1):1-5. doi: 10.1016/j.jphs.2016.08.001. Epub 2016 Aug 12. J Pharmacol Sci. 2016. PMID: 27581588 Free article. Review.

10

[Fascination with natural glycosides].

Ikeda T, Miyashita H, Nakano D, Nohara T. Ikeda T, et al. Among authors: nakano d. Yakugaku Zasshi. 2010 May;130(5):679-86. doi: 10.1248/yakushi.130.679. Yakugaku Zasshi. 2010. PMID: 20460864 Free article. Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results